January 28, 2025

New Member: Welcome in our cluster to Akribion Therapeutics GmbH

New Member: Welcome in our cluster to Akribion Therapeutics GmbH
Go back

Akribion Therapeutics is developing a unique, RNA-guided, nuclease-based technology for programmable cell depletion. Its G-dase® E nuclease has the ability to kill cells by shredding DNA and RNA, but only if there is a highly specific match between the guide RNA and an intracellular RNA sequence. This ensures that only the targeted cells are affected, leaving healthy cells unharmed.
Akribion is exploring applications in oncology, autoimmune diseases, fibrosis, and infectious diseases, as the technology can be quickly adapted to target different biomarkers and cells.

If you would like to learn more, please visit their Website.
Looking forward to your active participation!

Our latest News

discover more
SPT Labtech and Agilent Introduce Automated Target Enrichment Protocols for Genomic Workflows

SPT Labtech and Agilent Introduce Automated Target Enrichment Protocols for Genomic Workflows

Cambridge, UK, 08 October 2025: SPT Labtech, a pioneer in the design and development of laboratory automation and liquid handling solutions, and Agilent Technologies Inc. (“Agilent”), a global leader in analytical and clinical laboratory technologies, today announced the introduction of automated target enrichment protocols on SPT Labtech’s firefly®+ platform. Automating genomic workflows, the optimized Target […]

read more
PHOENIX fördert Forschung: Pharmazie Wissenschaftspreis für Pharmazeutische Technologie verliehen

PHOENIX fördert Forschung: Pharmazie Wissenschaftspreis für Pharmazeutische Technologie verliehen

Herzlichen Glückwunsch an JunProf. Dr. Philipp Uhl von der Universität Heidelberg und sein Team. Für PHOENIX ist das eine ganz besondere Auszeichnung, denn als approbierter Apotheker mit Schwerpunkt in der pharmazeutischen Forschung verbindet Philipp Uhl Praxis und Forschung – genau das, was die pharmazeutische Versorgung von morgen braucht. Die Forschung des Teams könnte die Arzneimitteltherapie verändern: […]

read more
No more problems with reflective surfaces

No more problems with reflective surfaces

Start-up nanoAR receives funding from a federal “exist”-Forschungstransfer grant for its anti-reflective surface technology Most people have been irritated by the reflection of sunlight on their smartphone display or their spectacles. Many solutions are available — but until now none for curved surfaces or situations with a wide range of light incidence angles. Scientists at […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp